Kalvista Pharmaceuticals, Inc. (KALV) — SC 13G/A Filings
All SC 13G/A filings from Kalvista Pharmaceuticals, Inc.. Browse 9 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (9)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Nov 4, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 13, 2024
-
FMR LLC & Abigail Johnson Slash KalVista Stake to 0.147%
— Feb 9, 2024 Risk: medium
FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have significantly reduced their stake in KalVista Pharmaceuticals, Inc. (KALV).
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX